Related Experiment Video
Updated: Oct 11, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Community-acquired pneumonia in infants: Not simply an acute event with complete recovery
Rotem Lapidot1, Jeffrey Vietri2, Melody Shaff3
1Boston University Schools of Medicine and Public Health, Boston, MA, USA; Boston Medical Center, Boston, MA, USA.
Insights
Hospitalized community-acquired pneumonia (CAP) in infants increases the risk of chronic respiratory disorders. This risk is higher when CAP occurs closer to preschool age, suggesting persistent inflammation.
Area of Science:
- Pediatric Respiratory Medicine
- Epidemiology
- Public Health
Background:
- Infant pneumonia can have lasting effects on lung development.
- Community-acquired pneumonia (CAP) is a common childhood illness with potential long-term respiratory consequences.
Purpose of the Study:
- To investigate the impact of hospitalized community-acquired pneumonia (CAP) in infancy on subsequent respiratory health.
- To determine if early-life CAP increases the risk of chronic respiratory disorders and recurrent pneumonia.
Main Methods:
- Retrospective matched-cohort study using de-identified electronic health records (2009-2018).
- Compared healthy infants hospitalized for CAP before age 2 with matched controls without pneumonia.
- Assessed outcomes including chronic respiratory disorders, reactive airway disease, and subsequent CAP hospitalizations between ages 2-5 years.
Main Results:
- Infant CAP patients (n=1,343) showed significantly higher rates of chronic respiratory disorders (11.6 vs. 4.9 per 100 patient-years; RR=2.4) and reactive airway disease (6.1 vs. 1.9; RR=3.2) compared to controls (n=6,715).
- Subsequent CAP hospitalizations were also more frequent in the CAP group (1.0 vs. 0.2 per 100 patient-years; RR=6.3).
- Outcomes were most pronounced in CAP patients whose initial hospitalization occurred in their second year of life.
Conclusions:
- Infant CAP is associated with a substantially increased risk of chronic respiratory disorders and reactive airway disease.
- The risk of these long-term respiratory issues is elevated when CAP occurs closer to preschool age.
- Findings support the hypothesis that persistent inflammation post-pneumonia contributes to chronic respiratory sequelae.
Background:
Pneumonia in infancy has been linked to long-term consequences for the rapidly developing lung. We examined the impact of hospitalized community-acquired pneumonia (CAP) on subsequent respiratory health.
Methods:
We conducted a retrospective matched-cohort study using the Optum® de-identified Electronic Health Record Dataset (2009-2018). Study population comprised healthy infants hospitalized for CAP ("CAP patients"), and matched comparators without pneumonia ("comparison patients"), before age 2 years. Study outcomes included any chronic respiratory disorder, reactive airway disease (asthma, hyperactive airway disease, recurrent wheezing), and CAP hospitalization occurring between age 2-5 years, and were evaluated overall as well as by age and etiology at first CAP hospitalization.
Results:
Study population totaled 1,343 CAP patients and 6,715 comparison patients. Rates per 100 patient-years and relative rates (RR) of study outcomes from age 2-5 years for CAP patients versus comparison patients were: any chronic respiratory disorder, 11.6 vs. 4.9 (RR = 2.4 [95% CI: 2.1-2.6]); reactive airway disease, 6.1 vs 1.9 (RR = 3.2 [2.6-3.8]); and CAP hospitalization, 1.0 vs 0.2 (RR = 6.3 [3.6-10.9]). Rates of study outcomes were highest among CAP patients who had their initial hospitalization in the second year of life.
Conclusions:
Infant CAP foreshadows an increased risk of subsequent chronic respiratory disorders, which may be elevated when CAP occurs closer to pre-school age (i.e., age 2-5 years). These findings are most consistent with the hypothesis that inflammation persists beyond the acute stage of pneumonia and plays a role in the development of chronic respiratory sequelae.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Cycle: Exhalation